A pharmacy benefit manager stopped covering a GLP-1 for obesity. Now there’s a lawsuit

When the major pharmacy benefit manager informed patients about the change this year, it suggested that there was “another covered medication that’s safe and effective for your condition and may cost less”: namely Wegovy, from Novo Nordisk, with which CVS Caremark announced a partnership just before...

Redirecting to full article...